1. Home
  2. ROIV vs DOV Comparison

ROIV vs DOV Comparison

Compare ROIV & DOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

N/A

Current Price

$38.91

Market Cap

28.7B

Sector

Health Care

ML Signal

N/A

Logo Dover Corporation

DOV

Dover Corporation

N/A

Current Price

$195.11

Market Cap

27.4B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ROIV
DOV
Founded
2014
1947
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
28.7B
27.4B
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
ROIV
DOV
Price
$38.91
$195.11
Analyst Decision
Strong Buy
Buy
Analyst Count
13
19
Target Price
$50.82
★ $238.00
AVG Volume (30 Days)
★ 7.1M
1.2M
Earning Date
11-09-2026
10-22-2026
Dividend Yield
N/A
★ 1.05%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 6.53
Revenue
$8,260,000.00
★ $6,992,118,000.00
Revenue This Year
$1,870.25
$7.60
Revenue Next Year
$271.46
$5.76
P/E Ratio
★ N/A
$30.62
Revenue Growth
N/A
★ 2.51
52 Week Low
$19.96
$181.66
52 Week High
$42.50
$237.54

Technical Indicators

Market Signals
Indicator
ROIV
DOV
Relative Strength Index (RSI) 54.07 38.19
Support Level $33.11 $192.65
Resistance Level $42.37 $217.44
Average True Range (ATR) 1.55 5.72
MACD -0.07 -2.07
Stochastic Oscillator 49.40 3.72

Price Performance

Historical Comparison
ROIV
DOV

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About DOV Dover Corporation

Founded in 1955 by George Ohrstrom, Dover has become an industrial behemoth through the acquisition of dozens of esteemed brands. The company is organized into five segments through which it designs and manufactures highly engineered components, such as vehicle repair, factory automation, welding, aerospace, fuel dispensing, printing, liquid handling, refrigeration, and can-making equipment. It has operations around the globe but generates over half of its revenue in the United States.

Share on Social Networks: